Paper40524980
Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy.
Ali MS and 3 others. Clin Pharmacol, 2025. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy. Papers, record 40524980. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40524980
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References151
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32337527 | Multifunctional sonosensitizers in sonodynamic cancer therapy. | Chem Soc Rev | 2020 | https://conductscience.org/library/papers/32337527 | PubMed |
| 2 | 10469134 | Selective targeting of an antioxidant to mitochondria. | Eur J Biochem | 1999 | https://conductscience.org/library/papers/10469134 | PubMed |
| 3 | 28236692 | Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue. | J Colloid Interface Sci | 2017 | https://conductscience.org/library/papers/28236692 | PubMed |
| 4 | 33329007 | Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33329007 | PubMed |
| 5 | 30048028 | Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions. | Angew Chem Int Ed Engl | 2019 | https://conductscience.org/library/papers/30048028 | PubMed |
| 6 | 36978874 | Rosemary (Rosmarinus officinalis L.) Glycolic Extract Protects Liver Mitochondria from Oxidative Damage and Prevents Acetaminophen-Induced Hepatotoxicity. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/36978874 | PubMed |
| 7 | 16638611 | Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. | Brain Res | 2006 | https://conductscience.org/library/papers/16638611 | PubMed |
| 8 | 30144423 | Targeting mitochondria in cancer: current concepts and immunotherapy approaches. | Transl Res | 2018 | https://conductscience.org/library/papers/30144423 | PubMed |
| 9 | 30173542 | Mitochondrial-targeted penetrating peptide delivery for cancer therapy. | Expert Opin Drug Deliv | 2018 | https://conductscience.org/library/papers/30173542 | PubMed |
| 10 | 32020724 | Triphenylphosphonium (TPP)-Based Antioxidants: A New Perspective on Antioxidant Design. | ChemMedChem | 2020 | https://conductscience.org/library/papers/32020724 | PubMed |
| 11 | 34943772 | A Mitochondria-Penetrating Peptide Exerts Potent Anti-Plasmodium Activity and Localizes at Parasites' Mitochondria. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34943772 | PubMed |
| 12 | 35644289 | Recent trends in the application of nanoparticles in cancer therapy: The involvement of oxidative stress. | J Control Release | 2022 | https://conductscience.org/library/papers/35644289 | PubMed |
| 13 | 28654243 | Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. | Chem Rev | 2017 | https://conductscience.org/library/papers/28654243 | PubMed |
| 14 | 30566834 | Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer. | Biomacromolecules | 2019 | https://conductscience.org/library/papers/30566834 | PubMed |
| 15 | 10751361 | Openings between defective endothelial cells explain tumor vessel leakiness. | Am J Pathol | 2000 | https://conductscience.org/library/papers/10751361 | PubMed |
| 16 | 26567518 | In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas. | Mol Pharm | 2015 | https://conductscience.org/library/papers/26567518 | PubMed |
| 17 | 21663778 | Targeted drug delivery to tumors: myths, reality and possibility. | J Control Release | 2011 | https://conductscience.org/library/papers/21663778 | PubMed |
| 18 | 37451568 | Nanotechnology-empowered strategies in treatment of skin cancer. | Environ Res | 2023 | https://conductscience.org/library/papers/37451568 | PubMed |
| 19 | 35994990 | Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer. | Colloids Surf B Biointerfaces | 2022 | https://conductscience.org/library/papers/35994990 | PubMed |
| 20 | 27585998 | Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures. | J Colloid Interface Sci | 2016 | https://conductscience.org/library/papers/27585998 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42619255 | Mitochondria-Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42619255 | PubMed |
| 42545462 | QSAR modeling and in vitro studies of the selective action of triphenylphosphonium salts as anticancer agents against the rhabdomyosarcoma cell line. | Med Chem Res | 2026 | https://conductscience.org/library/papers/42545462 | PubMed |
| 42348102 | The linker governs the organelle targeting of TPP⁺-modified zinc phthalocyanine photosensitizers. | Photochem Photobiol Sci | 2026 | https://conductscience.org/library/papers/42348102 | PubMed |
| 42099586 | Mitochondrial biology and immune crosstalk in breast cancer: therapeutic opportunities and challenges. | Front Immunol | 2026 | https://conductscience.org/library/papers/42099586 | PubMed |
| 42094737 | Nanomaterial-Mediated Targeting of Mitochondrial Metabolism: Strategies and Applications in Cancer Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42094737 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40524980
GET https://conductscience.org/api/papers/v1/40524980/references?page=2